Development of B-cell maturation antigen (BCMA)-specific CD8(+) cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma
JOURNAL OF CLINICAL ONCOLOGY(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined